أرسل هذا في رسالة قصيرة: Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy

 _    _      ___      _____    __   __    _  __  
| |  | ||   / _ \\   |__  //   \ \\/ //  | |/ // 
| |/\| ||  / //\ \\    / //     \ ` //   | ' //  
|  /\  || |  ___  ||  / //__     | ||    | . \\  
|_// \_|| |_||  |_|| /_____||    |_||    |_|\_\\ 
`-`   `-` `-`   `-`  `-----`     `-`'    `-` --`